Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study. [electronic resource] by
- Marchesi, Francesco
- Vacca, Michele
- Giannarelli, Diana
- Ipsevich, Francesco
- Pandolfi, Annino
- Gumenyuk, Svitlana
- Renzi, Daniela
- Palombi, Francesca
- Pisani, Francesco
- Romano, Atelda
- Spadea, Antonio
- Papa, Elena
- Canfora, Marco
- Pierelli, Luca
- Mengarelli, Andrea
Producer: 20181211
In:
Transfusion vol. 58
Availability: No items available.
|
|
67.
|
|
|
68.
|
|
|
69.
|
|
|
70.
|
|
|
71.
|
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma. [electronic resource] by
- Lisenko, Katharina
- Baertsch, Marc-Andrea
- Meiser, Renate
- Pavel, Petra
- Bruckner, Thomas
- Kriegsmann, Mark
- Schmitt, Anita
- Witzens-Harig, Mathias
- Ho, Anthony D
- Hillengass, Jens
- Wuchter, Patrick
Producer: 20171023
In:
Transfusion vol. 57
Availability: No items available.
|
|
72.
|
|
|
73.
|
|
|
74.
|
|
|
75.
|
|
|
76.
|
|
|
77.
|
|
|
78.
|
|
|
79.
|
|
|
80.
|
|